Thank you so much for investing in our mission. We are working hard for you as we believe serving our investors is of equal importance to serving those who need a new cancer therapy. You the investor drive development and the saving of lives. Those of you who are still considering joining our effort by investing, please note the campaign closes at midnight tonight.

Please let me know if you have any questions.

Thank you

Peter

“Because they have more life to live”
Peter F Travers
CEO
LifeBridge 10000, LLC
www.lifebridge10000.com

Thank you so much for investing in our mission. We are working hard for you as we believe serving our investors is of equal importance to serving those who need a new cancer therapy. You the investor drive development and the saving of lives. Those of you who are still considering joining our effort by investing, please note the campaign closes at midnight tonight.

Please let me know if you have any questions.

Thank you

Peter

“Because they have more life to live”
Peter F Travers
CEO
LifeBridge 10000, LLC
www.lifebridge10000.com

 https://clinicaltrials.gov/ct2/show/NCT02973789?term=lunar

Above is a picture from NovoCure’ s open phase 3 clinical trail for Non-Small Cell Lung Cancer (NSCLC). We are working hard to develop an advanced form of TTF that is not only more effective, but is designed from the ground up to treat late stage patients with disease in multiple locations, such as the lung and liver simultaneously. One of our main goals is to bring the therapy to these people who would otherwise not benefit.

But, there are hundreds of thousands of patients that can benefit from fixed array TTF. According to the American Cancer Society over 150,000 Americans will die from NSCLC this year, and even larger numbers worldwide.  You may be able to help some of them now. If you know of someone with NSCLC please share the link above to NovoCures trial at ClinicalTrials.gov. NSCLC patients working with their doctors can see if they qualify for this important 500-person phase 3 clinical trial. Those that received TTF and followed regimen in the phase 2 trial, fared over a hundred percent better than those on chemo alone.

If you can share this information and someone gets in the NovoCure trail and receives high quality extended life, you will understand the mission of LifeBridge 10000 in a new and personal way.

Peter Travers
CEO
LifeBridge 1000   

During our time together on StartEngine your funds have helped us:

• Make medical history by demonstrating a small 16 array prototype manipulating a tumor treating field through a human body. This first time this had ever been done.
• Tell the story in a proof of concept video (available on StartEngine).
• Supplied our engineers with the parts they needed to expand our prototype.
• Helped us finalize our U.S. patent work and receive a full U.S. patent. We are so thankful for this major milestone
• Helped us reach the final stages of a prototype large enough to treat lung cancer! (picture shown)
•   And you saw us expand our experienced advisory board. Combined we have 225 years of experience in the medical field, 8 startups 5 of which sold to larger concerns, 2 are ongoing businesses. Our advisors are on the boards of 7 companies and are named on 37 issued patents.

You can make a difference. Invest today!

Peter F Travers
CEO

As we speak our engineers are putting our new prototype through its paces. This prototype is larger than fixed array devices being tested on over 500 lung cancer patients in open phase 3 clinical trials.

Our device is built from the ground up to bring tumor treating field therapy to late stage patients with disease in multiple locations like the lung and liver simultaneously. You can help us get to clinical trials by investing today!  Thank you on behalf of those who have more life to live!  Only days left.

Peter Travers

CEO

LifeBridge 10000, LLC

https://www.youtube.com/watch?v=o88PXglcP_k

We have been asked “What if you don’t raise your highest goal on StartEngine?”. LifeBridge began raising funds through a Reg D offering before beginning on StartEngine. Although we are moving our emphasis to title 3 crowdfunding, friends family and accredited investors have continued supporting our research and mission. In January of this year $50,000 came in through our Reg D offering (see below). With your investment and additional commitments, we are approaching a total of $400,000 raised.

Our desire to move to crowd funding is our belief that you are more likely to be missional moving forward. You are OK with making a decent return and giving a percentage of profits to those who cannot afford treatment. We believe our mission will bring us all more profit as we gain the respect of the medical community as a company that cares. The bottom line is our effort will continue with or without crowdfunding. We hope and pray it will be with you, as institutional investors tend to strip away mission.

Please invest today, because they have more life to live! 

                     Link to Mad Money CNBC:     https://www.youtube.com/watch?v=0qAlyZhfetc

My wife presented in front of our radiation oncologist with significant back pain from her stage 4 cancer attacking nerves in her lower back. We had run out of chemo’s to use, so radiation was the only known way to keep the pain from becoming debilitating. My wife’s medical chart was still on paper at this point and was literally about 10 inches thick. 18 years and twelve re-occurrences of cancer made for a long history.

The doctor read silently, searching the file when a disappointing look came over his face. He said “about twelve years ago you had a breakout of cancer in your lower back and we used multiple treatments of radiation to resolve the issue. The pain you are experiencing now is in the same area. If we radiate that area again it could damage your nerves and the pain could be much worse. We should only radiate as a last resort”. Out of options is the dreaded destination of the cancer journey, but for us there was good news.

Before we get to the good news, let’s talk for a moment about a lifetime strategy for battling cancer. We learned through my wife’s 18-year battle with stage 4 breast cancer that you are going in to fight with a limited amount of ammunition. Once a certain type of ammunition is used up, you can be left without a defense. Some chemo’s have a lifetime limit to how many doses you can take, because the side effects can put you into a wheel chair or worse. As we learned above, radiating the same area twice is really discouraged, because of the nerve damage and other side effects.   

One of the problems with managing cancer is that many times it is managed from 1 re-occurrence to the next without a lifetime strategy. To be fair, that is because there have not been many options for developing a long-term plan. My wife is an example of how Tumor Treating Fields can bring about a new strategy. The day the doctor told us he did not recommend radiating Laurie’s back a second time, he also shared with us the location of the tumors causing the pain. That same day our team began building a new tumor treating field array to cover the area. One for the lower back and one in the front to create the tumor treating field. We called it the bikini array.

Within two weeks of wearing the new array the pain began to subside. Within a month the pain was gone. Tumor treating fields allowed Laurie to avoid a risky treatment. That is the point. Tumor treating fields can be used to create a long-term strategy of preserving various treatments for later use if needed. Here is another example.

Years earlier Laurie had a suspicious tiny spot on her pancreas. To biopsy it would be difficult. The procedure would require going down the throat, out the stomach, capture the sample and back out. Obviously, the doctors wanted to avoid the ordeal. So, we were asked to wait. Almost 3 full months later scans showed that the spot had gotten bigger and the biopsy was ordered. The results showed cancer. One of the most effective chemo’s was used to eliminate the tumor. Not only did Laurie have to lose her hair and go through yet another ordeal, but one our most powerful pieces of ammunition was used up. Years later when Laurie needed it more, it could not be used effectively.

If tumor treating fields were available there is a high probability we would not have had to wait those three months. The tiny tumor could have been eliminated by tumor treating fields and one of the most effective chemo’s could have been saved for later, if needed at all. Not to mention saving Laurie from going through another rough round of side effects. Tumor treating Fields have no side effects to date, only minor skin irritation. Here we are years later and fixed array tumor treating fields for pancreatic cancer is entering a phase 3 clinical trial, after proving to be over a 120% more effective than chemotherapy alone in a phase 2 trial.

Tumor treating fields can potentially change the way long term cancer is managed. Using it against new tumors when they are tiny. Not only does this avoid terrible side effects that strain the patient and whole family, but it preserves lifesaving therapies for later if needed.  

You are the key, make a difference today by investing, because they have more life to live!

Thank you for your time, please let me know if you have any questions.

Peter Travers

CEO

LifeBridge 10000, LLC